Lumida
/HQI
⌘K
Hirequest Inc

Hirequest Inc

HQI
$16.05USD+1.33%+0.21 today

MARKET CAP

223.1M

P/E (TTM)

34.9x

FWD P/E

DAY RANGE

$16 – $16

52W RANGE

$7
$19

AI Summary

Stalk
StalkMedium

HQI is exhibiting a constructive medium-term advance within Stage 2, supported by a clear sequence of higher highs and higher lows and dynamic support from rising EMAs and the 50 DMA despite a prevailing long-term downtrend. The recent pullback into the 9/20 EMA zone has found buyers but has not yet reclaimed the short EMAs decisively, leading to a neutral short-term timing assessment. Given the market stage and structural reinforcement, bullish engagement remains valid but warrants patience for a clear re-acceptance of key moving averages.

  • Manufacturing staffing revenue tripled vs. pre-pandemic levels
  • Revenue rose 6% YoY to $8.1M; net income reached $2.7M
  • Negative earnings yield and weak profitability metrics undermine valuation
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

HireQuest, Inc. (NASDAQ: HQI) operates within the staffing and recruitment industry, specializing in temporary staffing services across various sectors. The company has expanded its manufacturing staffing presence significantly, now operating in 35 states, which speaks to its growing dominance in the post-pandemic labor market. As manufacturers increasingly seek flexible labor solutions, HireQuest is well-positioned to meet these demands through its franchise model, emphasizing agility in response to fluctuating hiring dynamics.

Bull says

  • Manufacturing staffing revenue tripled vs. pre-pandemic levels
  • Revenue rose 6% YoY to $8.1M; net income reached $2.7M
  • SG&A fell 31.9% to $4M, boosting GAAP profitability
  • National accounts rollout and recruitment app drove 15% franchise growth
  • Immigration policy tailwinds improved labor supply since early 2025
  • Strong earnings revisions outlook and quality indicators support upside

Bear says

  • Negative earnings yield and weak profitability metrics undermine valuation
  • Size-related liquidity constraints could hamper operational scaling
  • Franchisee performance swings expose revenue to execution risk
  • Staffing demand remains sensitive to macroeconomic headwinds
  • Potential regulatory shifts in immigration may disrupt labor supply
  • High short interest signals investor skepticism on growth prospects

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 04-28-2026neutral

Transcript signals

Bull points

  • Operationally, cost reduction remains a key priority for us, and we made solid progress on this initiative in both the fourth quarter and the full fiscal year. Notably, we saw a 22.7% decline in SG&A compared to the fourth quarter of 2023, and a decline of 12.4% for the full year.
  • Steve will provide a more detailed update in his prepared remarks, but we're pleased to report that this expense has meaningfully come down in 2024, and we're confident that it will go down further in 2025.
  • We continue to stay active on the M&A front. Acquisitions are a key part of our broader strategy, and our franchise model allows us to identify and efficiently acquire businesses that expand our staffing footprint and enhance our scope of offerings.

Bear points

  • The market for permanent placement and executive search solutions has been weak and continued to impact the performance of MRI Network, which has fallen short of our internal expectations.
  • A combination of staffing headwinds and an unpredictable economy have caused employers to slow down or even halt their hiring decisions entirely, which has had a particularly negative impact on permanent placement and executive search.
  • Total revenue for the fourth quarter of 2024 was $8.1 million, compared with revenue of $9.8 million in the same quarter last year, a decrease of 17.2%.
Read full transcript analysis ›